Domann in the News

Our more than twenty year commitment supporting the entrepreneurial spirit continues with our ongoing sponsorship of conferences, symposiums and educational forums focused on bringing emerging growth companies together with investors, venture capitalists, and industry professionals.

You’ll find the latest Domann news below

Gregor Diagnostics and the Wisconsin Alumni Research Foundation (WARF) have entered into an exclusive license agreement.

September 2017

Marye Ellen Valentine joins Symic Bio, Emeryville, CA as Head, Clinical Operations

September 2017

ChemioCare, Inc. New York City retains Domann to recruit Chief Medical Officer

September 2017

Parvus Therapeutics, Calgary/San Francisco appoints David Schisla Vice President, Process Sciences & Manufacturing

September 2017

FluGen, Madison Wisconsin announces C. Boyd Clarke Has Been Named Executive Chairman

September 2017

Feriandas Greblikas, M.D. appointed Senior Medical Director-Neurology at Retrophin, Inc. San Diego

August 2017

Synthorx Inc., a San Diego biotechnology company using synthetic biology to discover and develop novel protein therapeutics, announced today the appointment of Marcos Milla, Ph.D. as senior vice president of research.

August 2017

Gemphire Therapeutics, Inc. Livonia, Michigan retains Domann-The Board Room Inc. to recruit a Chief Executive Officer

July 2017

Symic Bio; Emeryville, California retains the Domann Organization to recruit a Head, Discovery Biology

July 2017

Curtis Ruegg, Ph.D. joins Parvus Therapeutics as Chief Development Officer

July 2017

Domann-The Board Room Inc. launches Chief Executive Officer search for Parvus Therapeutics, Inc. Calgary/San Francisco

May 2017

Domann opens 4th office in Los Angeles, California

May 2017

Avexegen appoints Karl Sylvester, M.D. as their Chief Medical Officer

May 2017

Domann retained by Retrophin, San Diego to recruit a Vice President, Medical Development

September 2017

Domann continues to support the Midwest Life Sciences community with memberships in BioForward, the Wisconsin Technology Council, iBIO and MichBio

May 2017

Symic Bio appoints Glenn Prestwich, Ph.D. as their Vice President, Chemistry

May 2017

Titan Pharmaceuticals appoints Rekha Sathyanarayana as Vice President, Clinical Operations

May 2017

Gregor Diagnostics has added Dr. Jason Christiansen to the team as Acting Chief Scientific Officer-Advisor. The addition of Dr. Christiansen brings an experienced leader of diagnostic assay development, IVD regulatory knowledge, and clinical lab setup and operation to the team. He is an important addition as we develop a new screening test for prostate cancer.

May 2017

The Guardsmen of San Francisco “Service to Youth since 1947” elects, David E. Cookson, A. Horton Shapiro, Thomas H. Power and William A. Domann, Jr. to the Guardsmen Hall of Fame

April 2017

Gregor Diagnostics, Madison, Wisconsin adds Bob Wolfert to its Scientific Advisory Board

March 2017

Gregor Diagnostics is a molecular diagnostics company developing a revolutionary new screening test for prostate cancer. Gregor’s patient-friendly test will be the first diagnostic to detect prostate cancer at the earliest stages of the disease and differentiate between indolent and aggressive cancer upon detection. This will result in decreased overdiagnosis and overtreatment of indolent prostate cancer, and more effective detection of aggressive prostate cancer.

Patrick Doyle joins Synthorx Inc. as Chief Business Officer

January 2017

Synthorx Inc. is a biotechnology company using synthetic biology to discover and develop novel protein therapeutics. The company was founded based on important discoveries in Dr. Floyd Romesberg’s lab at The Scripps Research Institute.

Synthorx’s expanded genetic alphabet platform has the unique ability to drive the site-specific incorporation of multiple synthetic amino acids into proteins of any size, from small peptides to large biologics, and to manufacture these improved proteins at scale.

Synthorx’s unique platform expands the chemical and structural repertoire of protein therapeutics and uncovers new ways to modulate pharmacological properties of biologics, not possible with other technologies.

Synthorx is working internally and in collaboration with pharmaceutical companies toward the design and discovery of first-in- class drugs for a variety of therapeutic areas.
Synthorx’s investors include RA Capital Management, Avalon Ventures, and Correlation Ventures.

Biotech Showcase -Domann Exclusive Search Firm Sponsor, San Francisco, January 9 to 11, 2017

January 2017

SAN FRANCISCO, CA – January 7, 2015-Domann, Life Science Leadership- Executive Search That Delivers today announced their firm, The Domann Organization, Inc, as the exclusive search sponsor at The Biotech Showcase to be held in San Francisco January 11-13, 2016. “We are excited to continue Domann’s long standing tradition of sponsoring premier Industry events focused on promoting the entrepreneurial spirit of the Life Sciences” stated Bill Domann, Founder and Chief Executive Officer. “The Biotech Showcase provides a compelling vehicle for us to support a conference platform focused on emerging life science companies that drives innovation and deals, we are honored to participate and look forward to an outstanding and productive conference”. Domann has entered into an exclusive multi-year agreement with EBD Group.

The Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Now in its eighth year, Biotech Showcase 2016 is expected to attract upwards of 2,100 attendees representing over 1250 companies. The program includes lunch plenary sessions featuring top industry leaders and innovators speaking on industry- and time-relevant topics, as well as presentations from both private and public companies.

EBD Group’s overriding mission is to help collaborations get started across the life science value chain. To achieve our mission, we created a variety of partnering conferences that today have grown to become the largest and most productive conference platform in the industry. Each one of our eight landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings. EBD’s events annually attract more than 10,000 senior life science executives who engage in tens of thousands of one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in the life science industry.

About Domann, Inc:
The Domann Organization, Inc., is a retained search firm focused exclusively on delivering human capital. Founded in San Francisco during the biopharmaceutical industry’s infancy, Domann has built their practice by leveraging strategic industry knowledge and insight, relationship development, and talent cultivation. Their investment has resulted in Domann’s demonstrated advantage of securing the proven leadership talent providing the greatest potential for their Client’s strategic growth and success. Domann recruits Board, Chief Executive Officer, C-Suite, and other senior functional executives.

Recent client’s include: Ultragenyx Pharmaceuticals, NantKwest, CytomX Therapeutics, ArmaGen Inc., Deltanoid Pharmaceuticals, Assembly Biosciences, Parvus Therapeutics, and Swift Biosciences. Domann operates from three strategically located offices: San Francisco, San Diego, and Madison, WI with International partners in Europe and Asia Pacific.In 2014 Domann established The BOARD Room, Inc., to further complement and strengthen their existing practice. BOARD Room trends toward Board, Board Advisor, and Advisor Consultant work.

For additional information regarding Domann please visit the website at www.domann.net

Domannn contact Jovanna Bost, Vice President, Business Development at jbost@domann.net.

The Domann Organization continue to sponsor, support and attend the Early Stage Symposium Conference in Madison

November 2016

The Domann Organization, members of the Wisconsin Technology Council/Wisconsin Innovation Network continue to sponsor, support and attend the Early Stage Symposium Conference held in Madison every November.

The symposium is designed to unlock Wisconsin’s entrepreneurial potential by providing the right combination of ideas, innovation, intellectual property and investment – as well as hands-on instruction and advice targeted to early stage companies ready to make the leap.

It’s time to start planning for healthcare’s busiest week!
January 9–11, 2017 in San Francisco

October 2016

Registration numbers for Biotech Showcase™ are already up and we are forecasting another great event during the industry’s most important annual gathering. Presenting company slots are filling up fast and many hotels are already booked!

Domann, Life Science Leadership- Executive Search That Delivers today announced their firm Domann-The Board Room Inc. will continue as the exclusive search sponsor at The Biotech Showcase to be held in San Francisco January 9-11, 2017. “We are excited to continue Domann’s long standing tradition of sponsoring premier Industry events focused on promoting the entrepreneurial spirit of the Life Sciences” stated Bill Domann, Founder and Chief Executive Officer. “The Biotech Showcase provides a compelling vehicle for us to support a conference platform focused on emerging life science companies that drives innovation and deals, we are honored to participate and look forward to an outstanding and productive conference”. Domann has entered into an exclusive multi-year agreement with EBD Group.
The Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Now in its eighth year, Biotech Showcase 2016 is expected to attract upwards of 2,100 attendees representing over 1250 companies. The program includes lunch plenary sessions featuring top industry leaders and innovators speaking on industry- and time-relevant topics, as well as presentations from both private and public companies.

EBD Group’s overriding mission is to help collaborations get started across the life science value chain. To achieve our mission, we created a variety of partnering conferences that today have grown to become the largest and most productive conference platform in the industry. Each one of our eight landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings. EBD’s events annually attract more than 10,000 senior life science executives who engage in tens of thousands of one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in the life science industry.

About Domann, Inc:
The Domann Organization, Inc., is a retained search firm focused exclusively on delivering human capital. Founded in San Francisco during the biopharmaceutical industry’s infancy, Domann has built their practice by leveraging strategic industry knowledge and insight, relationship development, and talent cultivation. Their investment has resulted in Domann’s demonstrated advantage of securing the proven leadership talent providing the greatest potential for their Client’s strategic growth and success. Domann recruits Board, Chief Executive Officer, C-Suite, and other senior functional executives.

For additional information regarding Domann please visit the website at www.domann.net

Domann contact Jovanna Bost, Vice President, Business Development at jbost@domann.net.

Domann-The Board Room Inc. will be attending the John G. Watson Quick Pitch Competition

October 2016

Tech Coast Angels, one of the largest and most active angel investing organizations in the United States with more than 300 members in five regional networks will host the 10th anniversary event where technology startups will compete for cash awards.

DOMANN CELEBRATES 15 YEARS IN SAN DIEGO

SEPTEMBER 2016

Domann established in San Francisco in 1988 and opened our San Diego office in September of 2001 would like to thank the clients we have served over the past 15 years.

Allergan PLC on Tuesday said it agreed to acquire Tobira Therapeutics Inc., a biopharmaceutical company that develops therapies for liver diseases, in a deal worth as much as $1.7 billion, or 19 times Tobira’s previous market value.

September 2016

Tobira focuses on products that treat nonalcoholic steatohepatitis, or NASH, a common liver disease associated with obesity and type-2 diabetes. NASH occurs when the accumulation of liver fat is accompanied by inflammation and cellular damage, and it can lead to scarring of the liver and progress to cirrhosis, liver cancer and eventual liver failure.

Domann invited to attend Baird’s Healthcare Conference in New York September 7 & 8. 103 companies (94 public, nine private) attended the event, up from 88 last year. Baird hosts fireside chats, presentations, and investor dinners with company management teams.

September 2016

Domann-The Board Room Inc. will be attending the 2016 Wisconsin Biohealth Summit on September 27th. The event offers an opportunity to exchange ideas, learn new strategies, and create lasting partnerships with companies at the forefront of their industry.

Join us at the 2016 Wisconsin Biohealth Summit!

September 27th, 2016 Overture Center, Madison, WI

unnamed

Domann-The Board Room Inc. continues to support the Michigan Growth Capital Symposium; Ypsila, Michigan

May 2016

The Michigan Growth Capital Symposium is the premier venture event that annually showcases nearly 40 “Best of the Midwest” high-growth companies in new businesses and emerging technologies. As part of MGCS, the newly added “University Pitch Track” will feature emerging startups out of the University of Notre Dame, Indiana University, University of Michigan, University of Chicago…

Biotech Showcase 2016 Reports Record High Attendance This Year- Domann Key Leadership Sponsor

January 2016

CARLSBAD, Calif., and NEW YORK and SAN FRANCISCO, Jan. 27, 2016 /PRNewswire/ — A record number of life science industry executives attended the eighth annual Biotech Showcase™ investor and networking conference, held January 11–13 in San Francisco.

More than 2,500 executive-level delegates representing qualified private and public equity investors, industry analysts, bankers, pharmaceutical and biotechnology industry executives attended from 1,600 companies and participated in 5,650 one-to-one investor meetings.

Over 300 innovative company presentations took place featuring mid-small cap and private life sciences across the therapeutic spectrum as well as platform, diagnostic and tool companies hoping to pique the interest of the nearly 600 public, private and strategic investors in attendance.

“The widespread commercialization of the biotech industry presented life sciences investors and industry leaders with new opportunities and challenges this year as they gathered for this year’s Biotech Showcase. We are proud that the event has become a home base for the life sciences industry during the healthcare industry’s busiest week of the year,” said Sara Jane Demy, CEO of Demy-Colton Life Science Advisors.

“Although 2015 has been a volatile year for biotech, Biotech Showcase attendance is at an all time high. This speaks to the sustained interest within the investor community in biotech innovation,” said Anna Chrisman, Group Managing Director, EBD Group. “This year we provided more space, more one-on-one meetings which we hope resulted in more opportunities. It was overwhelmingly successful.”

Biotech Showcase is produced by Demy-Colton Life Science Advisors and EBD Group. Both organizations have a long history of producing high quality programs supporting the biotechnology and broader life sciences industry.

Biotech Showcase is powered by partneringONE®, the industry’s most advanced meeting system that enables delegates to efficiently identify and arrange meetings with potential investors.

Up-to-date coverage of Biotech Showcase, including panel videos and interviews, can be found on the Biotech Showcase website, onpartnering360:Insight, and on the partnering360 Blog.

The next edition of Biotech Showcase will be held January 9–11, 2017 in San Francisco.

Biotech Showcase -Domann Exclusive Search Sponsor, San Francisco, January 11-13, 2016

January 2016

SAN FRANCISCO, CA – January 7, 2015-Domann, Life Science Leadership- Executive Search That Delivers today announced their firm, The Domann Organization, Inc, as the exclusive search sponsor at The Biotech Showcase to be held in San Francisco January 11-13, 2016. “We are excited to continue Domann’s long standing tradition of sponsoring premier Industry events focused on promoting the entrepreneurial spirit of the Life Sciences” stated Bill Domann, Founder and Chief Executive Officer. “The Biotech Showcase provides a compelling vehicle for us to support a conference platform focused on emerging life science companies that drives innovation and deals, we are honored to participate and look forward to an outstanding and productive conference”. Domann has entered into an exclusive multi-year agreement with EBD Group.

The Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Now in its eighth year, Biotech Showcase 2016 is expected to attract upwards of 2,100 attendees representing over 1250 companies. The program includes lunch plenary sessions featuring top industry leaders and innovators speaking on industry- and time-relevant topics, as well as presentations from both private and public companies.

EBD Group’s overriding mission is to help collaborations get started across the life science value chain. To achieve our mission, we created a variety of partnering conferences that today have grown to become the largest and most productive conference platform in the industry. Each one of our eight landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings. EBD’s events annually attract more than 10,000 senior life science executives who engage in tens of thousands of one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in the life science industry.

About Domann, Inc:
The Domann Organization, Inc., is a retained search firm focused exclusively on delivering human capital. Founded in San Francisco during the biopharmaceutical industry’s infancy, Domann has built their practice by leveraging strategic industry knowledge and insight, relationship development, and talent cultivation. Their investment has resulted in Domann’s demonstrated advantage of securing the proven leadership talent providing the greatest potential for their Client’s strategic growth and success. Domann recruits Board, Chief Executive Officer, C-Suite, and other senior functional executives.

Recent client’s include: Ultragenyx Pharmaceuticals, NantKwest, CytomX Therapeutics, ArmaGen Inc., Deltanoid Pharmaceuticals, Assembly Biosciences, Parvus Therapeutics, and Swift Biosciences. Domann operates from three strategically located offices: San Francisco, San Diego, and Madison, WI with International partners in Europe and Asia Pacific.In 2014 Domann established The BOARD Room, Inc., to further complement and strengthen their existing practice. BOARD Room trends toward Board, Board Advisor, and Advisor Consultant work.

For additional information regarding Domann please visit the website at www.domann.net

Domannn contact Jovanna Bost, Vice President, Business Development at jbost@domann.net.

Three to be added to Menomonee Falls High School Wall of Recognition

December 2015

Menomonee Falls — An accomplished doctor and two chief executive officers will join the ranks on the Wall of Recognition at Menomonee Falls High School this year.

A sincere sense of giving back in a variety of ways is the common denominator that has earned William Domann, Jr., Tom Gross and Jacquelyn Marie (McLees) Paykel a place on the Wall of Recognition, according to creator Dick Woosencraft.

“I know all of this year’s inductees personally, and they are all very special people,” said Woosencraft, who created the Wall of Recognition, Fine Arts Hall of Fame and Athletic Hall of Fame in his final year as principal at the high school.

Now in its 12th year, the wall features alumni who have accomplished powerful things since they walked the school halls.

The public is invited to attend as this year’s inductees are honored at halftime during the boys varsity basketball game Friday, Dec. 11, at the school, W142N8101 Merrimac Drive. There will also be a reception following the game in the school media center.

William Domann, Jr.

Family roots run deep in Menomonee Falls for Domann, whose family legacy began in the village in 1918 when his grandfather, William G. Domann, started his medical practice and would later become one of the founders of Community Memorial Hospital.

Beyond that, Domann, Jr. credits his parents, both of whom served as president of the Menomonee Falls Historical Society, for instilling him with a drive to give back to the community.

In 1988, Domann, Jr. founded the Domann Organization, which assists early-stage life sciences companies in building executive leadership teams and boards. Today, the organization has offices in San Francisco and San Diego, California, as well as in Madison.

Domann, who lives in California with his wife and two daughters, has served on many nonprofit boards, including the San Francisco Boys & Girls Club, the northern California Arthritis Foundation, The Guardsmen-San Francisco and BioForward.

Tom Gross

From a very young age, Gross always knew what he wanted to do when he grew up. A passion for electricity developed into a lifelong career for Gross, who recently retired from his final role as vice chairman and chief operating officer for Eaton Corporation.

Before his retirement, he was responsible for Eaton’s global electrical business, which includes $14 billion of annual sales in more than 175 countries. One of his recent moves was to locate Eaton’s research and development center to Menomonee Falls, which in 2013 joined Prague, Czech Republic; Pune, India; and Southfield, Michigan, as one of four key research and development centers.

During his tenure at Eaton, Gross was responsible for acquisitions in Europe, China, the Middle East and the United States. He and his wife have lived throughout the country and in Europe. In addition to Eaton, Gross spent more than 20 years at Rockwell Automation, primarily in the Milwaukee area.

In addition to being on the board of governors of the National Electrical Manufacturer’s Association before retirement, Gross currently serves on as a board member of RPM, Inc., a publicly traded specialty coatings company with multiple brands, including Rust-Oleum paint.

Jacquelyn Marie (McLees) Paykel

Finding ways to live life to the fullest is of the utmost importance to Paykel, who has accomplished a lot since she graduated in 1981.

Since graduation, she has lived in Chile as an exchange student; graduated from medical school; completed a residency in obstetrics and gynecology; served in the United States Navy; and has practiced in private, academic and government facilities.

In addition, she has completed a fellowship in integrative medicine, published papers and engaged in public-speaking events, including appearances on television to share her views on women’s health.

But most importantly to her, she has raised three sons together with Stuart Paykel, a fellow 1981 Menomonee Falls alumnus.

AT A GLANCE

WHAT:Menomonee Falls High School Wall of Recognition induction

WHEN:Halftime during the varsity boys basketball game Friday, Dec. 11

WHERE:Menomonee Falls High School, W142 N8101 Merrimac Drive

The Domann Organization continue to sponsor, support and attend the Early Stage Symposium Conference in Madison

November 2015

The Domann Organization, members of the Wisconsin Technology Council/Wisconsin Innovation Network continue to sponsor, support and attend the Early Stage Symposium Conference held in Madison every November.

The symposium is designed to unlock Wisconsin’s entrepreneurial potential by providing the right combination of ideas, innovation, intellectual property and investment – as well as hands-on instruction and advice targeted to early stage companies ready to make the leap.

Human Longevity Inc. (HLI) Acquires Cypher Genomics, Inc.

November 2015

(SAN DIEGO, CA)—November 30, 2015—Human Longevity Inc. (HLI), the genomics based, informatics driven company, announced today that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions. The San Diego-based company has 14 employees who will join HLI including Cypher CEO and co-founder, Ashley Van Zeeland, Ph.D., who is now the head of HLI’s Pediatric Business. Financial details of the deal were not disclosed.

“Cypher Genomics has created important automated and scalable genome interpretation technology informed by additional expertise in genetics and biology that we believe will be invaluable to HLI’s business. The Cypher team, led by Dr. Van Zeeland, is a very impressive group of scientists who will be crucial in augmenting HLI’s already unparalleled and comprehensive genomic database business,” said J. Craig Venter, Ph.D., Co-founder and CEO, HLI.
Cypher has developed and marketed Mantis™, proprietary software which provides comprehensive and unbiased interpretation of genomic sequencing data enabling customers to rapidly uncover clinically significant variants. The company has also developed Coral™, a biomarker discovery service.

Industry collaborators for these products include: Celgene, Illumina and Sequenom. Cypher also has a number of key academic collaborations including: Scripps Translational Science Institute, University of Pennsylvania, and Clinic for Special Children. Cypher, in partnership with Lockheed Martin, was also recently selected as one of the finalists in the Genomics England bidding process to aid in genome interpretation as part of their 100,000 Genomes Project.
“At Cypher we saw an unmet need for automated interpretation of human genome sequencing data. We developed Mantis and Coral to provide rapid, automated, genome interpretation at scale enabling disease gene identification, population-based studies, diagnostic development and biomarker identification,” said Dr. Van Zeeland. “We look forward to joining the HLI team and to help advance HLI’s mission of applying the power of human genomics and informatics to improve healthcare.”

HLI has created the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. The company is developing and applying large-scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine. HLI enables customers in the pharmaceutical, biotechnology, insurance, academic and government sectors.

About Human Longevity Inc™.

Human Longevity Inc. (HLI) is the genomics-based, technology-driven company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine. HLI’s business also includes the HLI Health Nucleus, a genomic powered clinical research program which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health.

Domann sponsors the Michigan Growth Capital Symposium; Ypsila, Michigan

May 19-20, 2015

The Michigan Growth Capital Symposium is the premier venture event that annually showcases nearly 40 “Best of the Midwest” high-growth companies in new businesses and emerging technologies. As part of MGCS, the newly added “University Pitch Track” will feature emerging startups out of the University of Notre Dame, Indiana University, University of Michigan, University of Chicago…

Domann continues support as an annual sponsor the MidAmerica Healthcare Venture Forum.

March 6-7, 2015

The MidAmerica Healthcare Venture Forum gives promising early-stage companies a chance to pitch their products, business model or investment opportunity to active, eager angel, venture and strategic investors. Last year, companies presented in front of the likes of…

Domann continues membership and support to the Corporate Directors Forum

February 2015

Corporate Directors Forum is a nonprofit organization (501C-6) founded in 1991 to promote high standards of professionalism and ethics in the area of corporate governance and provide tools to help directors excel in the boardroom.

Core Values and Beliefs

  • Boards are strategic assets of corporations.
  • Education makes better directors.
  • Better directors make boards more effective.
  • More effective boards make better corporations.
  • We can all learn a lot from each other.

The Domann Organization’s “The Board Room, Inc.” is the first retained search firm to join The Water Council

January 2015

The Domann Organization’s “The Board Room, Inc.” is the first retained search firm to join The Water Council with an emphasis on providing CEO, Advisors and Independent Board members to start up companies.

The Water Council, the only organization of its kind in the United States, is successfully coalescing these tremendous attributes together into a powerful force. Created by leaders in both business and education, The Water Council is convening the region’s existing water companies and research clusters, developing education programs to train our talent, and building partnerships that cut across all sectors and geographic boundaries.

Milwaukee numbers among the world’s most significant hubs for water research, education, technology development and industry. Due to the work of The Water Council, a plethora of recent accomplishments have accelerated the region’s global impact and prestige.

For additional information on the Water Council please visit the website www.thewatercouncil.org

Domann launches The Board Room, Inc.

December 2014

The Domann Organization announced the formation of The Board Room Inc. The Board Room Inc., complements Domann’s existing recruitment platform with an emphasis on CEO, Board and Board Advisor searches. With private companies filing IPO’s at an unheard of pace and the exciting wave of entrepreneurial startups entering the marketplace, the dynamics and demand for quality Board Members and Advisors has dramatically increased. Our extensive network of leadership talent means we have immediate access and the unique ability to provide the steady and qualified hand of tenured leadership in the form of CEO, Board and Advisor leadership. For additional information on The Board Room Inc. please visit www.domann.net or www.BoardRoomInc.net.

The Domann Organization continue to sponsor, support and attend the Early Stage Symposium Conference in Madison

November 2014

The Domann Organization, members of the Wisconsin Technology Council/Wisconsin Innovation Network continue to sponsor, support and attend the Early Stage Symposium Conference held in Madison every November.

The symposium is designed to unlock Wisconsin’s entrepreneurial potential by providing the right combination of ideas, innovation, intellectual property and investment – as well as hands-on instruction and advice targeted to early stage companies ready to make the leap.

The 27th Biotech Meeting, Laguna Beach, CA

October 12-14, 2014

Bill Domann attends the gathering in Laguna Beach with industry CEO’s to discuss and review the industry’s current events.

BIO 2014 – San Diego, CA Domann hosts CEO/Board lunch

June 23, 2014 – June 26, 2014

The BIO International Convention is hosted by the Biotechnology Industry Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.

BIO performs many services for members, but none of them are more visible than the BIO International Convention. The BIO International Convention helps BIO fulfill its mission to help grow the global biotech industry. Profits from the BIO International Convention are returned to the biotechnology industry by supporting BIO programs and initiatives. BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotechnology innovation.

Bill Domann, Founder and CEO of The Domann Organization, Inc., elected to the Board of Directors of BIOforward and recently Co-Chaired the search selection committee to recruit the new CEO

January 2014

BIOforward, founded in 1987, is the member driven state association that is the voice of Wisconsin’s bioscience industry and a state chapter of the national Biotechnology Industry Organization, actively advocating on members behalf for public policy that supports the industry while providing opportunities for connections to funding, partners, and valuable resources. Members include key players from bioscience companies, universities, non-profits, service providers, investment capital firms, and government agencies.

Domann sponsors the Midwest Research University Network

October 8, 2013 – October 9, 2013

CATTEC VI
Leveraging connections for venture growth across the Midwest and beyond – CATTEC VI meets October 8-9, 2013 at Illinois Science + Tech Park in Skokie, IL.

Domann continues to support InvestMidwest Conference Kansas City, Kansas/St. Louis, Missouri

April 2013

InvestMidwest provides an opportunity for high growth companies from throughout the Midwest to present to an audience of over three hundred attendees including 60 -70 venture capital investors. The conference includes three presentation tracks: life sciences, technology and for the first time a food/ag/bioenergy presentation track.

The conference will showcase 45 companies in the three presentation tracks of life sciences, IT/general business and food/ag/bioenergy.